Andreas Kyriacou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andreas Kyriacou has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Jonathan Sahu
Department of Cardiology, The Northern General Hospital, Herries Road, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU, UK
2 shared publications- Andrew Horwood
Arrhythmia Nurse Specialist Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU
1 shared publication Anna Gregory
Arrhythmia Nurse Specialist Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU
1 shared publicationElizabeth Johnson
Cardiac Rehabilitation Nurse Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU
1 shared publicationGraeme Kirkwood
Consultant Cardiologist and Electrophysiologist Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU
1 shared publicationHamza Zafar
Cardiology Specialist Trainee Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU
1 shared publication
Latest Publications
- Open Access
- 1 February 2021
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 5 (2) , ytaa529
Radiofrequency ablation of ventricular tachycardia in Anderson–Fabry disease: a case series
Background: Cardiac involvement in Anderson–Fabry disease (AFD) can lead to arrhythmia, including ventricular tachycardia (VT). The literature on radiofrequency ablation (RFA) for the treatment of VT in AFD disease is limited.Case summary: We discuss RFA of drug-refractory VT electrical storm in three males with AFD. The first patient (53 years old) had extensive involvement of the inferolateral left ventricle (LV) demonstrated with cardiac magnetic resonance imaging (CMRI), with a left ventricular ejection fraction (LVEF) of 35%. Two VT ablation procedures were performed. At the first procedure, the inferobasal endocardial LV was ablated. Furthermore, VT prompted a second ablation, where epicardial and endocardial sites were ablated. The acute arrhythmia burden was controlled but he died 4 months later despite appropriate implantable cardioverter-defibrillator therapies for VT. The second patient (67 years old) had full-thickness inferolateral involvement demonstrated with CMRI and LVEF of 45%. RFA of several endocardial left ventricular sites was performed. Over a 3-year follow-up, only brief non-sustained VT was identified, but he subsequently died of cardiac failure. Our third patient (69 years old), had an LVEF of 35%. He had RFA of endocardial left ventricular apical disease, but died 3 weeks later of cardiac failure.Discussion: RFA of drug-refractory VT in AFD is feasible using standard electrophysiological mapping and ablation techniques, although the added clinical benefit is of questionable value. VT storm in the context of AFD may be a marker of end-stage disease.
- 1 February 2021
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 5 (2) , ytaa529
Open AccessRadiofrequency ablation of ventricular tachycardia in Anderson–Fabry disease: a case series
Background: Cardiac involvement in Anderson–Fabry disease (AFD) can lead to arrhythmia, including ventricular tachycardia (VT). The literature on radiofrequency ablation (RFA) for the treatment of VT in AFD disease is limited.Case summary: We discuss RFA of drug-refractory VT electrical storm in three males with AFD. The first patient (53 years old) had extensive involvement of the inferolateral left ventricle (LV) demonstrated with cardiac magnetic resonance imaging (CMRI), with a left ventricular ejection fraction (LVEF) of 35%. Two VT ablation procedures were performed. At the first procedure, the inferobasal endocardial LV was ablated. Furthermore, VT prompted a second ablation, where epicardial and endocardial sites were ablated. The acute arrhythmia burden was controlled but he died 4 months later despite appropriate implantable cardioverter-defibrillator therapies for VT. The second patient (67 years old) had full-thickness inferolateral involvement demonstrated with CMRI and LVEF of 45%. RFA of several endocardial left ventricular sites was performed. Over a 3-year follow-up, only brief non-sustained VT was identified, but he subsequently died of cardiac failure. Our third patient (69 years old), had an LVEF of 35%. He had RFA of endocardial left ventricular apical disease, but died 3 weeks later of cardiac failure.Discussion: RFA of drug-refractory VT in AFD is feasible using standard electrophysiological mapping and ablation techniques, although the added clinical benefit is of questionable value. VT storm in the context of AFD may be a marker of end-stage disease.
- 1 January 2020
- Published by Medinews (Cardiology), Ltd. in British Journal of Cardiology
- Vol. 27 (2) , 20
An exercise-based cardiac rehabilitation programme for AF patients in the NHS: a feasibility study
Introduction Atrial fibrillation (AF) is the most common cardiac rhythm disturbance in adults, estimated to affect 3.29% of the population in the UK in 2016.1 The condition is strongly associated with increased cardiovascular morbidity and mortality, in addition to reduced quality of life.2 The healthcare costs of ...
- 1 January 2020
- Published by Medinews (Cardiology), Ltd. in British Journal of Cardiology
- Vol. 27 (2) , 20
An exercise-based cardiac rehabilitation programme for AF patients in the NHS: a feasibility study
Introduction Atrial fibrillation (AF) is the most common cardiac rhythm disturbance in adults, estimated to affect 3.29% of the population in the UK in 2016.1 The condition is strongly associated with increased cardiovascular morbidity and mortality, in addition to reduced quality of life.2 The healthcare costs of ...